Fibroadipogenic progenitors are responsible for muscle loss in limb girdle muscular dystrophy 2B
Hogarth, Marshall W. (Research Center for Genetic Medicine. Children's Research Institute. Children's National Health System)
Defour, Aurelia (Research Center for Genetic Medicine. Children's Research Institute. Children's National Health System)
Lazarski, Christopher (Children's Research Institute. Children's National Health System)
Gallardo, Eduard (Institut d'Investigació Biomèdica Sant Pau)
Manera, Jordi Diaz (Institut d'Investigació Biomèdica Sant Pau)
Partridge, Terence A. (Department of Genomics and Precision Medicine. George Washington University School of Medicine)
Nagaraju, Kanneboyina (Department of Pharmaceutical Sciences. School of Pharmacy and Pharmaceutical Sciences. Binghamton University)
Jaiswal, JK. (Department of Genomics and Precision Medicine. George Washington University School of Medicine)
Universitat Autònoma de Barcelona

Data:	2019
Resum:	Muscle loss due to fibrotic or adipogenic replacement of myofibers is common in muscle diseases and muscle-resident fibro/adipogenic precursors (FAPs) are implicated in this process. While FAP-mediated muscle fibrosis is widely studied in muscle diseases, the role of FAPs in adipogenic muscle loss is not well understood. Adipogenic muscle loss is a feature of limb girdle muscular dystrophy 2B (LGMD2B) - a disease caused by mutations in dysferlin. Here we show that FAPs cause the adipogenic loss of dysferlin deficient muscle. Progressive accumulation of Annexin A2 (AnxA2) in the myofiber matrix causes FAP differentiation into adipocytes. Lack of AnxA2 prevents FAP adipogenesis, protecting against adipogenic loss of dysferlinopathic muscle while exogenous AnxA2 enhances muscle loss. Pharmacological inhibition of FAP adipogenesis arrests adipogenic replacement and degeneration of dysferlin-deficient muscle. These results demonstrate the pathogenic role of FAPs in LGMD2B and establish these cells as therapeutic targets to ameliorate muscle loss in patients.
Nota:	Altres ajuts: This work is supported by a MDA Career Development Award (MDA477331) to M.W.H. Additional financial support was provided by NIAMS (R01AR055686) and MDA (MDA277389) to J.K.J. and NIH (K26OD011171; R24HD050846, P50AR060836) grants to K.N. The authors acknowledge Carsten Bönnemann's contribution to this study. Microscopy imaging was performed at the CRI Cellular Imaging Core, which is supported by funds from CRI and NICHD (U54HD090257).
Drets:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.
Llengua:	Anglès
Document:	Article ; recerca ; Versió publicada
Matèria:	Cell biology ; Physiology ; Molecular medicine ; Diseases
Publicat a:	Nature communications, Vol. 10 Núm. 1 (january 2019) , p. 2430, ISSN 2041-1723

DOI: 10.1038/s41467-019-10438-z
PMID: 31160583

13 p, 6.7 MB

El registre apareix a les col·leccions:
Documents de recerca > Documents dels grups de recerca de la UAB > Centres i grups de recerca (producció científica) > Ciències de la salut i biociències > Institut de Recerca Sant Pau
Articles > Articles de recerca
Articles > Articles publicats